Exchange: NASDAQ·Updated 07:39 PM EDT
VYGR logo

VYGR Voyager Therapeutics Inc

$3.53
$0.08
(2.31%)
Today
Closed $3.54
$0.0099
(0.28%)
After Hours
Reported EarningsAug 6
Mkt Cap$218.13M
Vol406,269.00

About VYGR

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.
72

Bullish Sentiment

How do you feel about VYGR?

Advertisement|Remove ads.